Skip to main content
. 2021 Sep 1;15:722894. doi: 10.3389/fnins.2021.722894

FIGURE 3.

FIGURE 3

(A) Brain regions showing significant differences of gray matter volume (GMV) between the patient group and healthy control group at baseline. (B) Brain regions showing significant difference of GMV between the posttreatment and baseline in the patient group. (C) Conjunction analysis maps of GMV differences [(baseline vs. controls) ∩ (posttreatment vs. baseline)]. The warm color denotes the region where the GMV is larger, and the cool color denotes the region where the GMV is smaller. The color circle denoted the overlapped region of GMV differences.